Skip to Main content Skip to Navigation
Journal articles

Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: a pilot study

Abstract : Live attenuated vaccines have proved to be mostly valuable in the prevention of infectious diseases in humans, especially in developing countries. The safety and potency of vaccine, and the consistency of vaccine batch-to-batch manufacturing, must be proven before being administrated to humans. For now, the tests used to control vaccine safety largely involve animal testing. For live viral vaccines, regulations require suppliers to demonstrate the absence of neurovirulence in animals, principally in non-human primates and mice. In a search to reduce the use of animals and embracing the 3Rs principles (Replacement, Reduction, Refinement in the use of laboratory animals), we developed a new Blood-Brain Barrier Minibrain (BBB-Minibrain) in cellulo device to evaluate the neuroinvasiveness/neurovirulence of live Yellow Fever virus (YFV) vaccines. A pilot study was performed using the features of two distinct YFV strains, with the ultimate goal of proposing a companion test to characterize YFV neurovirulence. Here, we demonstrate that the BBB-Minibrain model is a promising alternative to consider for future replacement of YFV vaccine in vivo neurovirulence testing (see graphical abstract).
Document type :
Journal articles
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-01783750
Contributor : Catherine Tran <>
Submitted on : Wednesday, May 2, 2018 - 4:31:39 PM
Last modification on : Tuesday, October 20, 2020 - 10:50:46 AM
Long-term archiving on: : Tuesday, September 25, 2018 - 10:33:30 AM

Identifiers

Collections

Citation

Anaelle da Costa, Christophe Prehaud, Cécile Khou, Nathalie Pardigon, Aure Saulnier, et al.. Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: a pilot study. Biologicals, Elsevier, 2018, ⟨10.1016/j.biologicals.2018.03.004⟩. ⟨pasteur-01783750⟩

Share

Metrics

Record views

347

Files downloads

2016